Private equity firm KKR has taken a large stake in Henry Schein and reached a deal to add members to the company's board, the ...
Henry Schein (HSIC) stock in focus as KKR (KKR) builds stake and the company posts its preliminary Q4 2024 financials. Read ...
In a report released on January 29, Michael Cherny from Leerink Partners reiterated a Hold rating on Henry Schein (HSIC – Research Report), ...
Private equity firm KKR has taken a large stake in Henry Schein and plans to work with the distributor of medical products to ...
Henry Schein announced today that private equity firm KKR is investing $250 million in the medical products manufacturer and ...
Barrington analyst Michael Petusky raised the firm’s price target on Henry Schein (HSIC) to $90 from $82 and keeps an Outperform rating on the ...